Farrow Jeffrey S
CIK 0001405253
See RemarksDirector
Filings
13
Latest Jun 2, 2026
Issuers covered
3
Showing
13 of 13
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 75% | -0.1% | +1.3% | +3.0% | -6.7% |
| 90 days | 5 | 60% | +1.2% | +10.6% | +20.4% | -25.8% |
| 180 days | 5 | 0% | -40.5% | -7.4% | -0.1% | -104.2% |
| 365 days | 4 | 0% | -40.6% | -41.3% | -29.3% | -50.5% |
Issuers
Companies where Farrow Jeffrey S has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | 10 | Mar 19, 2026 |
| GBT | Global Blood Therapeutics, Inc. | 2 | Mar 3, 2022 |
| ACHV | Achieve Life Sciences, Inc. | 1 | Jun 2, 2026 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|